|
|
| G
|
Acsl1
|
acyl-CoA synthetase long-chain family member 1
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of ACSL1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023
|
|
| G
|
Adam17
|
ADAM metallopeptidase domain 17
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of ADAM17 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:46,601,583...46,649,344
|
|
| G
|
Adk
|
adenosine kinase
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of ADK mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr15:2,912,543...3,295,745
Ensembl chr15:2,912,544...3,295,745
|
|
| G
|
Alcam
|
activated leukocyte cell adhesion molecule
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of ALCAM mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876
|
|
| G
|
Angptl4
|
angiopoietin-like 4
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of ANGPTL4 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681
|
|
| G
|
Ankrd22
|
ankyrin repeat domain 22
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of ANKRD22 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of ANKRD22 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:241,052,235...241,083,737
Ensembl chr 1:241,052,237...241,105,559
|
|
| G
|
Arhgap24
|
Rho GTPase activating protein 24
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of ARHGAP24 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr14:7,105,200...7,488,437
Ensembl chr14:7,105,200...7,528,950
|
|
| G
|
Asah1
|
N-acylsphingosine amidohydrolase 1
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of ASAH1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr16:57,669,927...57,701,349
Ensembl chr16:57,669,750...57,718,305
|
|
| G
|
Asgr2
|
asialoglycoprotein receptor 2
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of ASGR2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr10:55,320,082...55,333,294
Ensembl chr10:55,320,091...55,333,263
|
|
| G
|
Batf
|
basic leucine zipper ATF-like transcription factor
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of BATF mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of BATF mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 6:111,084,717...111,107,052
Ensembl chr 6:111,084,717...111,107,052
|
|
| G
|
Bcap29
|
B-cell receptor-associated protein 29
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of BCAP29 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 6:53,910,209...53,950,206
Ensembl chr 6:53,910,216...53,949,963
|
|
| G
|
Bcl2a1
|
BCL2-related protein A1
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of BCL2A1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of BCL2A1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 8:98,596,806...98,604,890
Ensembl chr 8:98,596,650...98,604,890
|
|
| G
|
Bcl2l11
|
Bcl2-like 11
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of BCL2L11 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695
|
|
| G
|
Bcl2l14
|
Bcl2-like 14
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of BCL2L14 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of BCL2L14 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 4:168,948,919...168,989,450
Ensembl chr 4:168,948,946...168,990,079
|
|
| G
|
Ccr2
|
C-C motif chemokine receptor 2
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CCR2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059
|
|
| G
|
Ccr5
|
C-C motif chemokine receptor 5
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of CCR5 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CCR5 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594
|
|
| G
|
Cd274
|
CD274 molecule
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of CD274 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CD274 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:236,496,463...236,549,951
|
|
| G
|
Cd300lf
|
Cd300 molecule-like family member F
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of CD300LF mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr10:100,858,924...100,875,111
Ensembl chr10:100,858,924...100,875,022
|
|
| G
|
Cd38
|
CD38 molecule
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of CD38 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CD38 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr14:71,384,532...71,424,794
Ensembl chr14:71,384,532...71,424,505
|
|
| G
|
Cd40
|
CD40 molecule
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CD40 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
|
|
| G
|
Cd79a
|
CD79a molecule
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of CD79A mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of CD79A mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:89,621,460...89,625,813
Ensembl chr 1:89,621,460...89,625,812
|
|
| G
|
Cd79b
|
CD79b molecule
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of CD79B mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr10:91,739,134...91,742,312
Ensembl chr10:91,739,137...91,742,405
|
|
| G
|
Cd80
|
Cd80 molecule
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CD80 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540
|
|
| G
|
Cd9
|
CD9 molecule
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of CD9 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of CD9 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:159,942,560...159,975,444
|
|
| G
|
Cd93
|
CD93 molecule
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of CD93 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 3:156,345,019...156,351,537
Ensembl chr 3:156,345,019...156,351,537
|
|
| G
|
Cda
|
cytidine deaminase
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of CDA mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 5:155,839,929...155,866,541
Ensembl chr 5:155,839,929...155,866,541
|
|
| G
|
Ces1d
|
carboxylesterase 1D
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of CES1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CES1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:30,046,449...30,085,449
|
|
| G
|
Cfb
|
complement factor B
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CFB mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,955,776...3,981,740
|
|
| G
|
Cfl2
|
cofilin 2
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CFL2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 6:78,090,843...78,094,888
Ensembl chr 6:78,090,843...78,094,888
|
|
| G
|
Clec10a
|
C-type lectin domain containing 10A
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of CLEC10A mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr10:55,374,914...55,379,110
Ensembl chr10:55,374,887...55,379,108
|
|
| G
|
Clec7a
|
C-type lectin domain containing 7A
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of CLEC7A mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of CLEC7A mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 4:164,588,737...164,599,953
Ensembl chr 4:164,588,754...164,599,919
|
|
| G
|
Cmah
|
cytidine monophospho-N-acetylneuraminic acid hydroxylase
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CMAH mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr17:40,985,129...41,070,317
Ensembl chr17:41,011,641...41,070,252
|
|
| G
|
Cmtm8
|
CKLF-like MARVEL transmembrane domain containing 8
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CMTM8 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 8:123,360,168...123,425,291
Ensembl chr 8:123,360,170...123,425,276
|
|
| G
|
Cpd
|
carboxypeptidase D
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CPD mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr10:62,121,681...62,185,638
Ensembl chr10:62,121,679...62,185,638
|
|
| G
|
Cpm
|
carboxypeptidase M
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of CPM mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CPM mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 7:55,111,599...55,172,114
Ensembl chr 7:55,111,599...55,172,114
|
|
| G
|
Cr2
|
complement C3d receptor 2
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of CR2 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CR2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr13:109,207,034...109,244,980
Ensembl chr13:109,213,867...109,244,552
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
multiple interactions increases expression
|
ISO
|
bafilomycin A1 inhibits the reaction [gardiquimod results in increased expression of CXCL10 protein]; Chloroquine inhibits the reaction [gardiquimod results in increased expression of CXCL10 protein]; Phosphorothioate Oligonucleotides inhibits the reaction [gardiquimod results in increased expression of CXCL10 protein]
|
CTD |
PMID:26682054 |
|
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of CYP1B1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of CYP1B1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
| G
|
Dnaaf1
|
dynein, axonemal, assembly factor 1
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of DNAAF1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr19:64,532,859...64,560,942
Ensembl chr19:64,532,860...64,561,435
|
|
| G
|
Dnase1l1
|
deoxyribonuclease 1-like 1
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of DNASE1L1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr X:157,208,230...157,216,812
Ensembl chr X:157,208,230...157,216,711
|
|
| G
|
Ebi3
|
Epstein-Barr virus induced 3
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of EBI3 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 9:861,441...874,731
Ensembl chr 9:870,792...874,973
|
|
| G
|
Eeig2
|
EEIG family member 2
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of EEIG2 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of EEIG2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 2:199,296,582...199,351,449
Ensembl chr 2:199,296,582...199,351,449
|
|
| G
|
Ehd1
|
EH-domain containing 1
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of EHD1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of EHD1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:213,009,113...213,031,488
Ensembl chr 1:213,008,049...213,031,485
|
|
| G
|
Enpp2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of ENPP2 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of ENPP2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957
|
|
| G
|
Epha4
|
Eph receptor A4
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of EPHA4 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 9:86,263,982...86,406,744
Ensembl chr 9:86,263,982...86,406,755
|
|
| G
|
Epop
|
elongin BC and polycomb repressive complex 2 associated protein
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of EPOP mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr10:83,120,767...83,122,287
Ensembl chr10:83,119,970...83,122,423
|
|
| G
|
Ereg
|
epiregulin
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of EREG mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,311,485...17,325,260
|
|
| G
|
Etv3
|
ETS variant transcription factor 3
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of ETV3 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 2:175,263,389...175,278,217
Ensembl chr 2:175,263,459...175,278,208
|
|
| G
|
Ext1
|
exostosin glycosyltransferase 1
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of EXT1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of EXT1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 7:86,265,651...86,544,488
Ensembl chr 7:86,259,900...86,544,567
|
|
| G
|
Fabp5
|
fatty acid binding protein 5
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FABP5 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:93,672,458...93,676,127
|
|
| G
|
Fcar
|
Fc alpha receptor
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of FCAR mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of FCAR mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:78,669,119...78,703,223
|
|
| G
|
Ffar2
|
free fatty acid receptor 2
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of FFAR2 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FFAR2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:95,199,277...95,202,599
Ensembl chr 1:95,199,271...95,202,623
|
|
| G
|
Ffar3
|
free fatty acid receptor 3
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FFAR3 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:95,232,804...95,234,144
Ensembl chr 1:95,232,336...95,234,354
|
|
| G
|
Flt1
|
Fms related receptor tyrosine kinase 1
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FLT1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750
|
|
| G
|
Flvcr2
|
FLVCR choline and putative heme transporter 2
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of FLVCR2 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FLVCR2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 6:111,139,352...111,203,345
Ensembl chr 6:111,139,295...111,203,345
|
|
| G
|
Fpr2
|
formyl peptide receptor 2
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of FPR2 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FPR2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:67,449,637...67,458,272
Ensembl chr 1:67,449,637...67,458,272
|
|
| G
|
Frmd3
|
FERM domain containing 3
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FRMD3 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 5:92,810,989...93,077,326
Ensembl chr 5:92,810,736...93,077,325
|
|
| G
|
Fuca1
|
alpha-L-fucosidase 1
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of FUCA1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 5:153,436,262...153,453,512
Ensembl chr 5:153,436,248...153,453,511
|
|
| G
|
Fxyd6
|
FXYD domain-containing ion transport regulator 6
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of FXYD6 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FXYD6 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 8:54,575,578...54,602,715
Ensembl chr 8:54,575,591...54,602,715
|
|
| G
|
Gadd45b
|
growth arrest and DNA-damage-inducible, beta
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of GADD45B mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of GADD45B mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718
|
|
| G
|
Gapt
|
Grb2-binding adaptor protein, transmembrane
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of GAPT mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of GAPT mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 2:43,660,900...43,665,485
Ensembl chr 2:43,660,900...43,665,448
|
|
| G
|
Gas7
|
growth arrest specific 7
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of GAS7 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of GAS7 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr10:52,651,690...52,882,244
Ensembl chr10:52,651,690...52,882,244
|
|
| G
|
Gcsam
|
germinal center-associated, signaling and motility
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of GCSAM mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of GCSAM mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr11:68,658,350...68,669,598
Ensembl chr11:68,660,438...68,669,584
|
|
| G
|
Gng7
|
G protein subunit gamma 7
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of GNG7 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 7:9,348,148...9,411,924
Ensembl chr 7:9,348,218...9,411,923
|
|
| G
|
Gpr137b
|
G protein-coupled receptor 137B
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of GPR137B mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr17:92,987,792...93,026,003
Ensembl chr17:92,942,559...93,025,911
|
|
| G
|
Grk2
|
G protein-coupled receptor kinase 2
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of GRK2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:211,010,259...211,031,013
Ensembl chr 1:211,009,978...211,031,015
|
|
| G
|
Hamp
|
hepcidin antimicrobial peptide
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of HAMP mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297
|
|
| G
|
Hcar2
|
hydroxycarboxylic acid receptor 2
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of HCAR2 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of HCAR2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr12:38,387,163...38,389,149
Ensembl chr12:38,387,230...38,389,391
|
|
| G
|
Hebp1
|
heme binding protein 1
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of HEBP1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of HEBP1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 4:169,705,665...169,735,199
Ensembl chr 4:169,705,668...169,735,199
|
|
| G
|
Heg1
|
heart development protein with EGF-like domains 1
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of HEG1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr11:80,512,096...80,600,150
Ensembl chr11:80,512,096...80,600,092
|
|
| G
|
Hlx
|
H2.0-like homeobox
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of HLX mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr13:98,811,852...98,817,264
Ensembl chr13:98,811,856...98,817,264
|
|
| G
|
Hycc1
|
hyccin PI4KA lipid kinase complex subunit 1
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of HYCC1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of HYCC1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 4:12,024,692...12,131,504
Ensembl chr 4:12,024,739...12,131,501
|
|
| G
|
Ifi27
|
interferon, alpha-inducible protein 27
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of IFI27 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 6:128,355,312...128,361,783
Ensembl chr 6:128,355,079...128,361,781
|
|
| G
|
Ifna1
|
interferon, alpha 1
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of IFNA1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 5:108,143,240...108,143,809
Ensembl chr 5:108,143,240...108,143,809
|
|
| G
|
Ifng
|
interferon gamma
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of IFNG mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Ifnlr1
|
interferon, lambda receptor 1
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of IFNLR1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 5:153,203,597...153,225,911
Ensembl chr 5:153,203,597...153,225,911
|
|
| G
|
Ikzf1
|
IKAROS family zinc finger 1
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of IKZF1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of IKZF1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr14:90,468,696...90,556,522
Ensembl chr14:90,469,172...90,557,574
|
|
| G
|
Il10
|
interleukin 10
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of IL10 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of IL10 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il12b
|
interleukin 12B
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of IL12B mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194
|
|
| G
|
Il13ra1
|
interleukin 13 receptor subunit alpha 1
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of IL13RA1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr X:120,213,670...120,294,777
Ensembl chr X:120,214,075...120,274,461
|
|
| G
|
Il6
|
interleukin 6
|
increases expression multiple interactions increases secretion
|
ISO
|
gardiquimod results in increased expression of IL6 mRNA; gardiquimod results in increased expression of IL6 protein Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of IL6 mRNA]; Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of IL6 protein] gardiquimod results in increased secretion of IL6 protein LGMN gene mutant form inhibits the reaction [gardiquimod results in increased secretion of IL6 protein]; Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of IL6 protein]
|
CTD |
PMID:22916010 PMID:28003376 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Irf8
|
interferon regulatory factor 8
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of IRF8 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr19:65,699,284...65,721,066
Ensembl chr19:65,699,284...65,721,062
|
|
| G
|
Itgax
|
integrin subunit alpha X
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of ITGAX mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of ITGAX mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:192,140,089...192,171,151
Ensembl chr 1:192,149,905...192,171,151
|
|
| G
|
Itpkc
|
inositol-trisphosphate 3-kinase C
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of ITPKC mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of ITPKC mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:91,628,606...91,650,182
Ensembl chr 1:91,628,608...91,653,350
|
|
| G
|
Jaml
|
junction adhesion molecule like
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of JAML mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 8:54,281,596...54,313,655
Ensembl chr 8:54,281,644...54,313,500
|
|
| G
|
Kcne3
|
potassium voltage-gated channel subfamily E regulatory subunit 3
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of KCNE3 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of KCNE3 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:163,936,035...163,942,998
Ensembl chr 1:163,935,991...163,950,162
|
|
| G
|
Kcnj15
|
potassium inwardly-rectifying channel, subfamily J, member 15
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of KCNJ15 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr11:48,046,953...48,091,285
Ensembl chr11:48,035,655...48,092,457
|
|
| G
|
Kcnn4
|
potassium calcium-activated channel subfamily N member 4
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of KCNN4 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:89,084,306...89,102,279
Ensembl chr 1:89,086,814...89,102,275
|
|
| G
|
Kctd12
|
potassium channel tetramerization domain containing 12
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of KCTD12 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr15:86,214,786...86,220,725
Ensembl chr15:86,214,840...86,224,539
|
|
| G
|
L3mbtl3
|
L3MBTL histone methyl-lysine binding protein 3
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of L3MBTL3 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of L3MBTL3 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:20,807,679...20,908,609
Ensembl chr 1:20,808,973...20,908,608
|
|
| G
|
Lag3
|
lymphocyte activating 3
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of LAG3 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of LAG3 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 4:159,398,930...159,407,001
Ensembl chr 4:159,398,932...159,406,669
|
|
| G
|
Lair1
|
leukocyte-associated immunoglobulin-like receptor 1
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of LAIR1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of LAIR1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:79,140,850...79,261,546
Ensembl chr 1:79,198,311...79,258,037
|
|
| G
|
Lamp3
|
lysosomal-associated membrane protein 3
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of LAMP3 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr11:94,657,817...94,726,451
Ensembl chr11:94,661,399...94,726,195
|
|
| G
|
Lck
|
LCK proto-oncogene, Src family tyrosine kinase
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of LCK mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 5:147,172,642...147,201,267
Ensembl chr 5:147,172,642...147,201,267
|
|
| G
|
Ldlrad3
|
low density lipoprotein receptor class A domain containing 3
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of LDLRAD3 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of LDLRAD3 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 3:108,694,528...108,936,330
Ensembl chr 3:108,694,528...108,936,368
|
|
| G
|
Lgmn
|
legumain
|
multiple interactions
|
ISO
|
LGMN gene mutant form inhibits the reaction [gardiquimod results in increased secretion of IL6 protein]
|
CTD |
PMID:22916010 |
|
NCBI chr 6:127,308,913...127,347,355
Ensembl chr 6:127,308,913...127,347,328
|
|
| G
|
Lilra5
|
leukocyte immunoglobulin like receptor A5
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of LILRA5 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:79,011,865...79,073,860
Ensembl chr 1:79,045,546...79,050,111
|
|
| G
|
LOC100912356
|
interferon alpha-1-like
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of IFNA5 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of IFNA5 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 5:108,343,570...108,346,248
|
|
| G
|
Lpxn
|
leupaxin
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of LPXN mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of LPXN mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:219,353,319...219,387,743
Ensembl chr 1:219,353,708...219,387,742
|
|
| G
|
Lrg1
|
leucine-rich alpha-2-glycoprotein 1
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of LRG1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of LRG1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 9:1,034,691...1,036,937
Ensembl chr 9:1,034,679...1,037,337
|
|
| G
|
Manba
|
mannosidase beta
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of MANBA mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of MANBA mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 2:226,583,968...226,676,520
Ensembl chr 2:226,583,917...226,676,517
|
|
| G
|
Map3k5
|
mitogen-activated protein kinase kinase kinase 5
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of MAP3K5 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898
|
|
| G
|
Map3k8
|
mitogen-activated protein kinase kinase kinase 8
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of MAP3K8 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of MAP3K8 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr17:58,078,175...58,098,455
Ensembl chr17:58,078,320...58,098,452
|
|
| G
|
Marco
|
macrophage receptor with collagenous structure
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of MARCO mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of MARCO mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr13:34,169,011...34,210,340
Ensembl chr13:34,169,011...34,201,255
|
|
| G
|
Mcoln2
|
mucolipin TRP cation channel 2
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of MCOLN2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 2:237,714,100...237,762,979
Ensembl chr 2:237,714,084...237,762,978
|
|
| G
|
Mgst1
|
microsomal glutathione S-transferase 1
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of MGST1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of MGST1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:172,760,886...172,776,875
|
|
| G
|
Mpzl3
|
myelin protein zero-like 3
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of MPZL3 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of MPZL3 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 8:54,257,235...54,277,422
Ensembl chr 8:54,257,226...54,279,665
|
|
| G
|
Mreg
|
melanoregulin
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of MREG mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of MREG mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 9:81,236,019...81,291,601
Ensembl chr 9:81,236,019...81,291,310
|
|
| G
|
Ms4a6a
|
membrane spanning 4-domains A6A
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of MS4A6A mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of MS4A6A mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:217,826,261...217,839,606
Ensembl chr 1:217,826,261...217,850,013
|
|
| G
|
Nabp1
|
nucleic acid binding protein 1
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of NABP1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 9:57,570,326...57,625,926
Ensembl chr 9:57,618,505...57,626,052
|
|
| G
|
Ndufa12
|
NADH:ubiquinone oxidoreductase subunit A12
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of NDUFA12 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of NDUFA12 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 7:30,658,316...30,685,302
Ensembl chr 7:30,658,322...30,686,300
|
|
| G
|
Nek6
|
NIMA-related kinase 6
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of NEK6 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 3:42,693,994...42,766,026
Ensembl chr 3:42,693,971...42,767,773
|
|
| G
|
Nemp1
|
nuclear envelope integral membrane protein 1
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of NEMP1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 7:65,399,297...65,424,054
Ensembl chr 7:65,399,381...65,424,055
|
|
| G
|
Nexn
|
nexilin (F actin binding protein)
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of NEXN mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of NEXN mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 2:243,846,736...243,878,268
Ensembl chr 2:243,846,433...243,887,114
|
|
| G
|
Nup214
|
nucleoporin 214
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of NUP214 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 3:35,652,841...35,738,323
Ensembl chr 3:35,652,858...35,739,192
|
|
| G
|
P2rx7
|
purinergic receptor P2X 7
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of P2RX7 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr12:39,550,531...39,594,984
Ensembl chr12:39,540,567...39,595,193
|
|
| G
|
Paqr8
|
progestin and adipoQ receptor family member 8
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of PAQR8 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of PAQR8 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 9:30,808,921...30,858,599
Ensembl chr 9:30,808,923...30,861,043
|
|
| G
|
Pdcd1lg2
|
programmed cell death 1 ligand 2
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of PDCD1LG2 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of PDCD1LG2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:236,572,497...236,637,490
Ensembl chr 1:236,565,526...236,637,490
|
|
| G
|
Pid1
|
phosphotyrosine interaction domain containing 1
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of PID1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of PID1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 9:92,732,471...92,951,168
Ensembl chr 9:92,734,214...92,750,070
|
|
| G
|
Pim1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of PIM1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr20:7,556,496...7,560,747
Ensembl chr20:7,556,113...7,561,764
|
|
| G
|
Plagl2
|
PLAG1 like zinc finger 2
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of PLAGL2 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of PLAGL2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 3:162,155,554...162,168,748
Ensembl chr 3:162,155,554...162,168,748
|
|
| G
|
Plekhg1
|
pleckstrin homology and RhoGEF domain containing G1
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of PLEKHG1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:42,612,023...42,841,727
Ensembl chr 1:42,612,122...42,841,719
|
|
| G
|
Plod2
|
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of PLOD2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 8:101,964,318...102,047,022
Ensembl chr 8:101,964,318...102,047,022
|
|
| G
|
Ppp1r17
|
protein phosphatase 1, regulatory subunit 17
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of PPP1R17 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 4:86,544,024...86,560,839
Ensembl chr 4:86,544,121...86,560,835
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of PTGS2 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of PTGS2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Ptx3
|
pentraxin 3
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of PTX3 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of PTX3 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 2:152,797,563...152,803,372
Ensembl chr 2:152,781,955...152,803,372
|
|
| G
|
Rab33a
|
RAB33A, member RAS oncogene family
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of RAB33A mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr X:132,572,133...132,584,255
Ensembl chr X:132,572,148...132,584,254
|
|
| G
|
Rassf4
|
Ras association domain family member 4
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of RASSF4 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of RASSF4 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 4:151,569,984...151,605,203
Ensembl chr 4:151,569,984...151,604,883
|
|
| G
|
Rbp7
|
retinol binding protein 7
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of RBP7 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 5:165,169,700...165,177,427
Ensembl chr 5:165,172,785...165,177,399
|
|
| G
|
Rcbtb2
|
RCC1 and BTB domain containing protein 2
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of RCBTB2 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of RCBTB2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr15:54,729,367...54,774,004
Ensembl chr15:54,729,332...54,793,313
|
|
| G
|
Rgs16
|
regulator of G-protein signaling 16
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of RGS16 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of RGS16 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr13:68,421,480...68,443,312
Ensembl chr13:68,438,120...68,443,313
|
|
| G
|
Rnd1
|
Rho family GTPase 1
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of RND1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of RND1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 7:131,700,321...131,707,392
Ensembl chr 7:131,700,321...131,707,392
|
|
| G
|
Rnf130
|
ring finger protein 130
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of RNF130 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr10:34,843,920...34,957,130
Ensembl chr10:34,843,915...34,960,408
|
|
| G
|
Rnf144b
|
ring finger protein 144B
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of RNF144B mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of RNF144B mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr17:17,637,564...17,786,685
Ensembl chr17:17,639,079...17,769,037
|
|
| G
|
RT1-DMb
|
RT1 class II, locus DMb
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of HLA-DMB mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of HLA-DMB mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr20:4,695,009...4,702,560
Ensembl chr20:4,695,010...4,702,246
|
|
| G
|
Sdc2
|
syndecan 2
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of SDC2 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SDC2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 7:66,012,405...66,125,101
Ensembl chr 7:66,108,853...66,126,294
|
|
| G
|
Slamf1
|
signaling lymphocytic activation molecule family member 1
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of SLAMF1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SLAMF1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr13:86,802,708...86,837,890
Ensembl chr13:86,802,708...86,837,890
|
|
| G
|
Slamf7
|
SLAM family member 7
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SLAMF7 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr13:86,668,060...86,688,222
Ensembl chr13:86,668,060...86,686,341
|
|
| G
|
Slc30a1
|
solute carrier family 30 member 1
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of SLC30A1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SLC30A1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr13:106,022,019...106,025,892
Ensembl chr13:106,022,019...106,025,892
|
|
| G
|
Slc4a10
|
solute carrier family 4 member 10
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of SLC4A10 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SLC4A10 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 3:67,050,925...67,367,637
Ensembl chr 3:66,770,954...67,367,646
|
|
| G
|
Slco4a1
|
solute carrier organic anion transporter family, member 4a1
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SLCO4A1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 3:187,936,735...187,955,873
Ensembl chr 3:187,936,820...187,955,871
|
|
| G
|
Smco4
|
single-pass membrane protein with coiled-coil domains 4
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of SMCO4 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SMCO4 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 8:20,594,633...20,646,916
Ensembl chr 8:20,627,338...20,646,916
|
|
| G
|
Smim3
|
small integral membrane protein 3
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of SMIM3 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SMIM3 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr18:56,200,458...56,252,778
Ensembl chr18:56,200,459...56,227,379
|
|
| G
|
Smpdl3a
|
sphingomyelin phosphodiesterase, acid-like 3A
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of SMPDL3A mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SMPDL3A mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr20:37,679,004...37,701,979
Ensembl chr20:37,678,964...37,704,260
|
|
| G
|
Socs1
|
suppressor of cytokine signaling 1
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of SOCS1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SOCS1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:5,389,334...5,391,847
|
|
| G
|
Socs2
|
suppressor of cytokine signaling 2
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of SOCS2 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SOCS2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 7:31,890,564...31,932,092
Ensembl chr 7:31,874,463...31,930,423
|
|
| G
|
Socs3
|
suppressor of cytokine signaling 3
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SOCS3 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,690,976...103,704,825
|
|
| G
|
Sort1
|
sortilin 1
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of SORT1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SORT1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 2:198,609,466...198,690,481
Ensembl chr 2:198,612,148...198,690,481
|
|
| G
|
Sos1
|
SOS Ras/Rac guanine nucleotide exchange factor 1
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SOS1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 6:20,286,117...20,363,350
Ensembl chr 6:20,286,117...20,363,350
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SPP1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Sucnr1
|
succinate receptor 1
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SUCNR1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 2:146,368,858...146,380,360
Ensembl chr 2:146,368,858...146,380,360
|
|
| G
|
Taf4b
|
TATA-box binding protein associated factor 4b
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of TAF4B mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr18:6,227,299...6,360,970
Ensembl chr18:6,227,345...6,356,275
|
|
| G
|
Tapbp
|
TAP binding protein
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of TAPBP mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr20:4,958,821...4,967,958
Ensembl chr20:4,959,926...4,971,834
|
|
| G
|
Tbxas1
|
thromboxane A synthase 1
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of TBXAS1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 4:68,631,841...68,803,959
Ensembl chr 4:68,631,838...68,803,969
|
|
| G
|
Tcf7l2
|
transcription factor 7 like 2
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of TCF7L2 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of TCF7L2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 1:264,791,335...264,984,225
Ensembl chr 1:264,791,335...264,984,225
|
|
| G
|
Tfrc
|
transferrin receptor
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of TFRC mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of TFRC mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318
|
|
| G
|
Thbs1
|
thrombospondin 1
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of THBS1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402
|
|
| G
|
Tifa
|
TRAF-interacting protein with forkhead-associated domain
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of TIFA mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of TIFA mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 2:218,927,724...218,942,111
Ensembl chr 2:218,909,915...218,956,224
|
|
| G
|
Tifab
|
TIFA inhibitor
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of TIFAB mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr17:8,438,622...8,441,750
Ensembl chr17:8,433,862...8,444,360
|
|
| G
|
Tlr7
|
toll-like receptor 7
|
increases activity increases expression multiple interactions
|
ISO
|
gardiquimod results in increased activity of TLR7 protein gardiquimod results in increased expression of TLR7 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of TLR7 mRNA]
|
CTD |
PMID:26682054 PMID:28003376 |
|
NCBI chr X:30,644,324...30,670,796
Ensembl chr X:30,644,355...30,672,151
|
|
| G
|
Tlr8
|
toll-like receptor 8
|
multiple interactions increases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of TLR8 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr X:30,708,714...30,733,104
Ensembl chr X:30,708,033...30,737,079
|
|
| G
|
Tmem14c
|
transmembrane protein 14C
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of TMEM14C mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of TMEM14C mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr17:23,939,501...23,945,622
Ensembl chr17:23,939,509...23,959,055
|
|
| G
|
Tnf
|
tumor necrosis factor
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of TNF mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of TNF mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnip3
|
TNFAIP3 interacting protein 3
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of TNIP3 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of TNIP3 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 4:96,197,019...96,237,357
Ensembl chr 4:96,140,768...96,238,534
|
|
| G
|
Tpra1
|
transmembrane protein adipocyte associated 1
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of TPRA1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 4:122,921,304...122,932,519
Ensembl chr 4:122,921,323...122,932,517
|
|
| G
|
Vav1
|
vav guanine nucleotide exchange factor 1
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of VAV1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of VAV1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 9:2,248,856...2,295,905
Ensembl chr 9:2,248,914...2,296,922
|
|
| G
|
Vrk2
|
VRK serine/threonine kinase 2
|
multiple interactions decreases expression
|
ISO
|
Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of VRK2 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr14:104,514,815...104,635,549
Ensembl chr14:104,514,100...104,720,933
|
|
| G
|
Wdfy1
|
WD repeat and FYVE domain containing 1
|
increases expression multiple interactions
|
ISO
|
gardiquimod results in increased expression of WDFY1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of WDFY1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 9:88,459,613...88,541,215
Ensembl chr 9:88,489,227...88,541,186
|
|
| G
|
Ypel4
|
yippee-like 4
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of YPEL4 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of YPEL4 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 3:90,222,060...90,227,395
Ensembl chr 3:90,222,803...90,227,381
|
|
| G
|
Zfp467
|
zinc finger protein 467
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of ZNF467 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of ZNF467 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr 4:78,716,473...78,725,829
Ensembl chr 4:78,716,666...78,723,135
|
|
| G
|
Znrf1
|
zinc and ring finger 1
|
decreases expression multiple interactions
|
ISO
|
gardiquimod results in decreased expression of ZNRF1 mRNA Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of ZNRF1 mRNA]
|
CTD |
PMID:28003376 |
|
NCBI chr19:56,403,816...56,490,901
Ensembl chr19:56,405,728...56,490,881
|
|